Protein imbalances that increase brain cell excitability may explain why individuals with Alzheimer's disease (AD) who also ...

The adoption of the FDA-approved Alzheimer's drug, Leqimbi, has slowed down in the U.S. as more experts grow hesitant about ...

Opens in a new tab or window The first drug shown to slow ... it can delay the progression of the disease by a few months when given to people with mild symptoms. Some experts say the delay ...

The drug, which is called aducanumab, cannot cure it but Biogen says it slows down the rate at which it progresses, essentially meaning people stay more like themselves for longer. This came as a ...

With more people dying from Alzheimer’s disease than ever before, experts are emphasizing ... medications largely treat symptoms and slow progression of disease — but several trials are ...

There has been a breakthrough in the research on the disease amyotrophic lateral sclerosis (ALS). Scientists at Umeå ...

For her entire life, college student Olivia Cook had only a small degree of central vision. It was as if she was watching the ...

Several billion years ago, a genetic arms race began between bacteria and their viral killers. This seemingly eternal struggle continues today, with implications for diseases killing tens of thousands ...

p. 461. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD ...

Additionally, two new drugs for Alzheimer's have displayed significant potential in slowing the progression of the disease during its initial phases. These medications target a substance called ...

April is Parkinson's Disease awareness month, and there is a new drug that has promising results for people with Parkinson's.

A fiber implanted into the hippocampus could allow scientists to study real-time changes in the brain as the disease takes hold. "Good" cholesterol has been associated with a reduced risk of ...